Literature DB >> 26246402

Coronary vasomotor function in infarcted and remote myocardium after primary percutaneous coronary intervention.

Paul F A Teunissen1, Stefan A J Timmer1, Ibrahim Danad1, Guus A de Waard1, Peter M van de Ven2, Pieter G Raijmakers3, Adriaan A Lammertsma3, Albert C Van Rossum1, Niels van Royen1, Paul Knaapen1.   

Abstract

OBJECTIVE: In patients with acute myocardial infarction (AMI), coronary vasomotor function is impaired in the myocardial territory supplied by the culprit artery and in remote myocardium supplied by angiographically normal vessels. The aim was to investigate the temporal evolution of coronary vasodilatory reserve in patients with AMI by use of [(15)O]H2O positron emission tomography, after successful percutaneous coronary intervention.
METHODS: 44 patients with AMI and successful revascularisation by percutaneous coronary intervention were included. Subjects were examined 1 week and 3 months after AMI with [(15)O]H2O positron emission tomography to assess the coronary flow reserve (CFR). CFR was defined as the ratio of myocardial blood flow (MBF) during hyperaemia and rest. Additionally, 45 age-matched and sex-matched subjects underwent similar scanning procedures and served as controls.
RESULTS: At baseline, CFR averaged 1.81±0.66 in infarcted myocardium versus 2.51±0.81 in remote myocardium (p<0.01). In comparison, CFR in the control group averaged 4.16±1.45 (p=0.001 vs both). During follow-up, the CFR increased to 2.74±0.85 in infarcted myocardium (p<0.01), and to 2.85±0.70 in remote myocardium (p<0.01). This was predominantly due to an increase in hyperaemic MBF, from 1.62±0.54 mL/min/g to 2.19±0.68 mL/min/g in infarcted myocardium (p<0.001), and 2.17±0.54 mL/min/g to 2.60±0.65 mL/min/g in remote myocardium (p<0.001).
CONCLUSIONS: CFR in infarcted and remote myocardium is impaired 1 week after AMI. After 3 months vasomotor function partially recovers. However, as compared with control patients, MBF remains impaired in culprit and reference territories in patients with AMI. CLINICAL TRIAL REGISTRATION: NTR3164. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26246402     DOI: 10.1136/heartjnl-2015-307825

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  5 in total

1.  Temporal Changes in Coronary Hyperemic and Resting Hemodynamic Indices in Nonculprit Vessels of Patients With ST-Segment Elevation Myocardial Infarction.

Authors:  Nina W van der Hoeven; Gladys N Janssens; Guus A de Waard; Henk Everaars; Christopher J Broyd; Casper W H Beijnink; Peter M van de Ven; Robin Nijveldt; Christopher M Cook; Ricardo Petraco; Tim Ten Cate; Clemens von Birgelen; Javier Escaned; Justin E Davies; Maarten A H van Leeuwen; Niels van Royen
Journal:  JAMA Cardiol       Date:  2019-08-01       Impact factor: 14.676

2.  MR findings of microvascular perfusion in infarcted and remote myocardium early after successful primary PCI.

Authors:  Anne Bethke; Limalanathan Shanmuganathan; Christian Shetelig; David Swanson; Geir Øystein Andersen; Jan Eritsland; Nils Einar Kløw; Pavel Hoffmann
Journal:  PLoS One       Date:  2018-11-09       Impact factor: 3.240

3.  Can C-11 Acetate PET Be a Feasible Option for Assessing Non-Culprit Lesion in STEMI Patients?

Authors:  Eunjung Kong
Journal:  J Cardiovasc Imaging       Date:  2022-07

4.  Acute Microvascular Impairment Post-Reperfused STEMI Is Reversible and Has Additional Clinical Predictive Value: A CMR OxAMI Study.

Authors:  Alessandra Borlotti; Michael Jerosch-Herold; Dan Liu; Dafne Viliani; Alessia Bracco; Mohammad Alkhalil; Giovanni Luigi De Maria; Keith M Channon; Adrian P Banning; Robin P Choudhury; Stefan Neubauer; Rajesh K Kharbanda; Erica Dall'Armellina
Journal:  JACC Cardiovasc Imaging       Date:  2019-01-16

5.  Different Microcirculation Response Between Culprit and Non-Culprit Vessels in Patients With Acute Coronary Syndrome.

Authors:  Yoon-Sung Jo; Hyeyeon Moon; Kyungil Park
Journal:  J Am Heart Assoc       Date:  2020-05-15       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.